Immunovant (IMVT) Change in Taxes (2019)

Immunovant's (IMVT) quarterly Change in Taxes came in at $95000.0 in Q4 2019, up 201.49% on a QoQ basis from $31510.0 in Q3 2019.

Analysis

Immunovant (IMVT) Change in Taxes (2019) Analysis & Trends

Immunovant (IMVT) has 1 years of Change in Taxes data on file, last reported at $95000.0 in Q4 2019.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Change in Taxes (Qtr)
1	Vertex Pharmaceuticals	138.43 Bn	130.58 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.18 Bn	77.19 Bn	3.93 Bn	-
3	Argenx Se	63.34 Bn	58.15 Bn	1.37 Bn	-
4	Moderna	57.98 Bn	52.85 Bn	52.00 Mn	-
5	Revolution Medicines	43.98 Bn	43.98 Bn	-	-
6	BeOne Medicines	39.92 Bn	34.82 Bn	1.53 Bn	-
7	Alnylam Pharmaceuticals	35.42 Bn	32.11 Bn	992.69 Mn	-
8	Royalty Pharma	28.42 Bn	27.58 Bn	-	-
9	Insmed	27.36 Bn	26.20 Bn	358.27 Mn	-
10	Immunovant	8.12 Bn	8.12 Bn	-	-

Historic Data

Download Data